Kristine “Kiki” Oustrup Laureijs, is a contemporary visual artist exploring new frontiers.

Using visual and multimedia art installations, her works offers both visionary and sometimes provoking commentaries on contemporary social, political and cultural issues.

Currently she is exploring multicultural identity in a globalising world for FACES of the FUTURE.

A graduate in International Business & Marketing, she originally joined the Scandinavian fashion group METROPOL (St. Martins) in Denmark, before moving to Hong Kong as Head of Innovation for global lifestyle brand DIESEL.

After a move to France in 2001, Kiki became the co-founder of the French trend agency Style-Vision, where she consulted several global luxury brands and initiated the Style-Vision Round Table events, supported by the Financial Times.

In 2009, Kristine arrived in Singapore to establish Qi GLOBAL, an open innovation platform for sustainability, with the mission of “Human Progress in Harmony with Nature”.

During 2012-2015, she pivoted the online platform into Business Innovation Culture, a change management company, served on the advisory board of the Singapore Institute for Innovation & Productivity (SiPi) and as the Chairwoman of the growing CEO Innovation Network.

With her innovative ideas gaining continuous recognition, she has been appointed “Goodwill Ambassador of Copenhagen” under the patronage of His Royal Highness, Prince Joachim of Denmark, to represent and promote the country of her birth.

Dorjee is a social entrepreneur who has founded 11 companies with 2 acquisitions and 3 exits and assets sales [cvMail (2000), Elevate Education (2002), AsiaGroove (2004), Honey RoastedTV (2005), Joosed (2005), Carbon Conservation (2007), Carbon Agro (2009), Whogives (2012), SnapClip (2014), Freedoms (2014) and Home Group (2014)].

Dorjee is a founder and director of the Home Group which owns equity in companies that work in the areas of conservation, agriculture, philanthropy, technology and financial innovation. Dorjee is also a founder and director of Carbon Conservation which owns equity in large scale sustainability and carbon conservation projects globally with project partners and clients such as Rio Tinto, Bank of America Merrill Lynch, Olam and Twitter. One such project in Aceh, Indonesia, won the Carbon Finance Deal of the Year award and was also the subject of an award winning documentary, “The Burning Season”, narrated by Hugh Jackman which explained how orangutan conservation and avoided deforestation could be tied in to generate alternative monetary incentives. The African Rainforest Conservancy honoured Dorjee with an Earth Day Award and by naming a newly discovered blue spotted species of chameleon from the Tanzania rainforest – the “Kinyongia dorjeesuni”.

His most recent undertaking is a solution for busy undergraduates called UNSWOT – a simple idea, an enabling digital platform, to engage the students face-to-face online with a conversation, a discussion, a debate on wide ranging issues such as challenges facing UN, Australian immigration policies, international obligations and climate change. Last month, this new idea was presented to University of North South Wales Vice Chancellor Ian Jacobs and 51 other Heads of Schools.

Dorjee has also been named one of TIME Magazine’s Heroes of the Environment, a World Economic Forum Global Leaders of Tomorrow, CPA Top 20 Business Leaders, one of Esquire Magazine’s 5 Gentlemen of Philanthropy, one of the Young Leaders by The Australian newspaper, he has won the Asialink Leaders Program Alumni Award, was named an Asia Society 21 Fellow, a World Cities Summit Future Leader, is the Chairman Nexus Youth Philanthropy Singapore Conference, on the board for the Nexus Youth Philanthropy Australia Conference and his work has been covered in Wall Street Journal, Fortune, TIME, Esquire, ABC, PBS, BBC, Discovery, CNBC, Sydney Morning Herald, The Australian and other media outlets.

Dorjee has a law degree, commerce degree and diploma of Asian Studies (Mandarin) from the University of New South Wales, studied at North Sydney Boys High. Growing up in Sydney he now shares his time between Singapore, San Francisco, Sydney and other project locations.

Humanity & Science at crossroads
Dr. Vikram Raut M.D.

As said by Prof. ShinyaYamanaka’s [ 2012 Nobel Laureate] Medical science consisted of medicine, which concerned with humanity, and science deals with discoveries. But the science is of no use if it cannot serve humanity at right time, at right place and importantly at right price. These words refused to leave me ears and kept me focused on my goal of making quality healthcare affordable, accessible and available.

During my tenure in medical college I had seen many end stage liver disease cases waiting helplessly due to either shortage of facilities or shortage of donor. This healthcare scenario led to an urge to do my bit for ailing liver disease patients. I did fellowship at Graduate School of Medicine, Kyoto Japan, which is the pioneering and largest living-donor transplantation centre.

I learnt the skills of living-donor liver transplants which is majorly helpful in India wherein Cadaveric transplants are rare due to social stigma. To overcome the scarcity of organ donors, I studied transplantation across blood groups (Usually transplants are done only if the donor and the recipient share the same blood group).

I could contribute with a newer protocol for liver transplantation across the blood-groups without need of splenectomy, which is published in leading journal of transplantation and followed by most of centres.Further, I trained for a year in Liver Transplantation at Hospital Beujon, University of Paris-VII, France and later at the Asan Medical Centre in Seoul, South Korea. Meanwhile I got an opportunity to work as a committee member with International Liver Transplant Society and giving my inputs on standardising various treatment protocols, maintaining database of liver transplantation across the globe.

I was on a path wherein there was no scarcity of opportunity and glamour associated with the same.But that is not what I had started off for. It was important for me to come back and strengthen my base in India and focus on implementation of my knowledge. I can say I have taken the initial steps towards my dream, but it’s a long way to go.

I aim to take this fight much ahead as I strongly believe ‘Healthcare is not privilege; it’s a necessity, a right. Access to healthcare is right of every individual , The right… as a society we are failing to provide. Not only in developing countries that the millions are far away from basic healthcare but even in developed countries Obamacare in USA, NHS in UK are struggling?

Healthcare is usually juggled between governments who are not able to ensure quality and the private providers who are not able to assure affordably. According to the WHO, Millions are pushed to poverty due to healthcare expenses. We need to address the current healthcare challenges with socialist brain and capitalist heart. So that we can ensure accessibility for common man to quality healthcare.

Raja Manohar
Managing Director & Co-Founder
Hexolabs Interactive Technologies,
Chennai, India

Rajamanohar, Co-Founder and Managing Director of Hexolabs Mobile Technologies. He heads an interdisciplinary research team that develops grounded solutions around mobile telephony services to reach out to the rural masses. With the increasing penetration of mobile services, especially in multilingual rural India. He strongly believes that hybrid of voice & data mobile technology solutions hold the key to the future of healthcare, governance and entertainment information services.

He holds a graduate degree in Industrial design from Indian Institute of Technology Kanpur. He has been a frequent speaker at industry events on the topics of Mobile VAS and Social Media. Raja was recently conferred the ‘TED India Fellowship 2009’, an international fellowship program designed to bring together young world-changers and trailblazers who have shown exceptional accomplishment. He was then conferred ‘National Internet Exchange of India(NIXI) Fellowship, a program to groom the next generation leaders in the field of Internet technology, Policy and Knowledge economy.

Hexolabs is a provider of products, platforms and hosted-on-demand services for mobile VAS services on the mobile phone to Enterprises, Media companies and Wireless Carriers. The company was founded in collaboration with the Indian Institute of Technology, Kanpur, India

CEO Rajamanohar has been honored as a Young global Leader in 2012 by World Economic Forum, Geneva. He was MIT TR 35 Social Innovator awardee.

Werner Wutscher
Chief Executive Officer and Founder
New Venture Scouting

Werner Wutscher is a Member of the Board of resPACT, the Austrian Business Council for Sustainable Development. He also works as consultant and business angel in the start-up area. Wutscher scouts interesting start-ups around the world and serves as a facilitator for start-up ventures. As an angel investor he focuses on e-commerce and retail. He also serves as director on different boards in Austria, Mumbai and Amman. Werner was COO and CFO of Rewe International. Prior, he worked as Secretary-General of the Ministry for Agriculture, Forestry, Environment and Water Management of Austria, and he served as a special adviser to the Minister for Agriculture and in a public company. Wutscher is Vice-President of the Ökosoziales Forum Europe and President of the National Park Hohe Tauern. He was awarded “Business Angel of 2012” and is Member of the Board of the Austrian Business Angel Association. Wutscher obtained a law degree from Karl-Franzens University in Graz and holds a Master’s degree from the Harvard Kennedy School.

Kim Elena Ionescu
Sustainability Manager

Since 1995, Counter Culture Coffee has been dedicated to sourcing unique coffees from exceptional producers, roasting them with care and sharing them – along with our passion for all things coffee – with coffee lovers. As the company grew in the early 2000s, its buying team built a reputation for traveling to remote coffee farms to establish relationships with farmers and co-operatives based on mutual respect and trust. In addition to helping us tell compelling stories, these relationships are crucial to both the taste of our product and the sustainability of our company: not only do we get insight about the environmental and social conditions of the farm, we are also able to work together with growers to develop the potential for delicious coffee that everyone from coffee farmer to coffee drinker recognizes as highly valuable.

With delicious coffee and higher prices as a platform, we are able to influence coffee producers to adopt agricultural practices that will ensure long-term productivity and environmental health. We are also in a position to respond to the needs of coffee-producing communities and help strengthen their capacity to continue growing coffee and thrive, as opposed to simply surviving. In keeping with our commitment to being great students of coffee as well as educators, we both share our knowledge with farmers and connect them to resources as well as learning from them and spreading good ideas and successful techniques to farmers in our global network.

Though coffee grows in upwards of fifty countries around the world and demand for it is increasing every year, the volatile global market for green, unroasted coffee makes farming coffee a risky livelihood, especially for the smallholder farmers who produce more than 50% of the world’s supply (and an even higher percentage of the really good stuff). Coffee’s ability to survive and successfully adapt to global challenges like climate change, economic instability and population pressure demands that we work collaboratively within our supply chains and across to connect communities in pursuit of shared long-term goals.

The growth of the market for high-quality, or specialty, coffee, over the past decade is inspiring: as coffee lovers seek to know more about where their morning cup comes from, how its made and why it tastes the way it does, coffee has gotten better and better. Sustaining this growth and upward trajectory, however, relies on our ability to communicate clearly, collaborate and deliver on the promise of this extraordinary product. The road is full of challenges, but we are excited to work on them together.

Profile:
Kim Elena Ionescu, is a green coffee buyer and the manager of sustainability for the internationally lauded coffee-roasting company Counter Culture Coffee, which is headquartered in Durham, North Carolina. When she’s not on the road visiting coffee producers, Kim works to advance the company’s environmental and social commitments in the communities where its employees and customers live.

V. C. Sangar*, L. Samant and Dr. A. S. Chowdhary
Haffkine Institute for Training, Research and Testing, Mumbai, INDIA

ABSTRACT

Ebola virus disease (EVD) is a severe, often fatal illness with a death rate of up to 90%. EVD formerly known as “Ebola haemorrhagic fever (EHF)”. Till now due to 36 EVD outbreaks 4140 number of cases reported while 2,510 lost their lives during outbreaks. EVD is caused due to ebola virus which is linear, single-stranded, negative-sense RNA molecule and belongs to the family Filoviridae. Mode of transmission of Ebola into the human population is through close contact with the blood, secretions, organs or other bodily fluids of infected animals. The incubation period I defined as “the time interval from infection with the virus to onset of symptoms”.

The incubation period for ebola virus is 2-21 days. EV infection can be diagnosed by Enzyme-linked Immunosorbent Assay (ELISA), antigen detection tests, serum neutralization test, reverse-transcriptase polymerase chain reaction (RT-PCR) and virus isolation by using viro cell line. No effective antiviral drug and no specific licensed vaccines are available in international market for EV. EV outbreak was limited in African countries but globalization has made everyone vulnerable to this outbreak and therefore an urgent solution & investment in its cure is required.

To overcome this lack of awareness and knowledge part about ebola virus this review article in planned.

Keywords:
Ebola virus (EV), Ebola viral disease (EVD), Ebolavirus species, clinical features and treatments.

Ebola virus disease (EVD) is a severe, often fatal illness with a death rate of up to 90%. EVD formerly known as “Ebola haemorrhagic fever (EHF)”. In this article, the concise overview of the outbreaks of ebola viral disease (EVD) history, structure of ebola virus, mode of transmission, clinical features, diagnosis, treatments and preventive measures are given below-

OUTBREAK OF EBOLA VIRUS DISEASE (EVD)
Ebola virus disease (EVD) affects humans and nonhumans primates like chimpanzees, gorillas and monkeys. Till now 36, EVD outbreaks recorded. From 36 outbreaks, 4140 number of cases reported while 2,510 lost their lives during outbreaks. The first EVD outbreak was appeared in 1976 in Nzara, Sudan and in Yambuku, Democratic Republic of Congo. The latter was in a village situated near the Ebola River, from which the disease takes its name 1. Table 1 shows the chronology of previous ebola virus disease outbreaks from 1st September 1976 to 6th August 2014. The World Health Organization, in partnership with the Ministries of Health in Guinea, Sierra Leone, Liberia, and Nigeria announced a cumulative total of 1,779 suspect and confirmed cases of Ebola virus disease (EVD) and 961 deaths, as of August 6, 2014. Of the 1,779 clinical cases, 1,134 cases have been laboratory confirmed for Ebola virus infection 2. Table 2 shows number of incident and death cases reported during ebola virus disease outbreaks from 1st September 1976 to 6th August 2014.

TABLE. 1: SHOWS THE CHRONOLOGY OF PREVIOUS EBOLA VIRUS DISEASE OUTBREAKS FROM 1ST SEPTEMBER 1976 TO 6TH AUGUST 2014.

TABLE. 2: SHOWS NUMBER OF INCIDENT AND DEATH CASES REPORTED DURING EBOLA VIRUS DISEASE OUTBREAKS FROM 1ST SEPTEMBER 1976 TO 6TH AUGUST 2014.

EBOLA VIRUS (EV)
Ebola virus disease (EVD) is sever haemorrhagic fever caused due to EV. According to the International Committee on Taxonomy of Viruses, ebola virus belongs to the family Filoviridae. Filovirus particles are ~80 nm in diameter and found in the form of twisted filaments 3. This Ebola virus (EV) genome is 19kb long and 4.2×106 Da with seven open reading frames encoding structural proteins including the virion envelope glycoprotein (GP), nucleoprotein (NP), and matrix proteins VP24 and VP40; nonstructural proteins, including VP30 and VP35; and the viral polymerase 4. The GP open reading frame of Ebola virus gives rise to two gene products namely, a soluble 60-70 kDa protein (sGP) and a full-length 150-170 kDa protein (GP) that inserts into the viral membrane through transcriptional editing 5. It is linear, single-stranded, negative-sense RNA molecule. The EV virion is pleomorphic, producing ‘U’-shaped, ‘6’-shaped or circular forms but the predominant forms of the virion most frequently seen by electron microscope are long tubular structures 6.

Ebola virus comprises of 5 distinct species namely- 1) Bundibugyo ebolavirus (BDBV), 2) Zaire ebolavirus (EBOV), 3) Reston ebolavirus (RESTV), 4) Sudan ebolavirus (SUDV) and 5) Taï Forest ebolavirus (TAFV). Out of these 5 species, BDBV, EBOV, and SUDV are associated with large EVD outbreaks in Africa. The RESTV can infect humans but no illness or death in humans has been reported till date. This species predominantly found in Philippines and the People’s Republic of China 1. Table 3 shows death rates as per 5 ebola virus species from 1st September 1976 to 6th August 2014.

TABLE. 3: SHOWS DEATH RATES AS PER 5 EBOLA VIRUS SPECIES FROM 1ST SEPTEMBER 1976 TO 6TH AUGUST 2014.
MODE OF TRANSMISSION

Mode of transmission of Ebola into the human population is through close contact with the all bodily fluids of infected animals and persons 7. In Africa, infection has been documented through the handling of infected chimpanzees, gorillas, fruit bats, monkeys, forest antelope and porcupines found ill or dead or in the rainforest 8,9. Ebola able to spreads in the community through human-to-human transmission, with infection resulting from direct contact like broken skin or mucous membranes with the blood, secretions, organs or other bodily fluids of infected people and indirect contact with environments contaminated with such fluids 6. Sexual contact is also major route of transmission for ebola virus. Men who have recovered from the EVD can transmit the virus through their semen for up to 7 weeks after recovery from illness. Ebola virus was isolated from semen 61 days after onset of illness in a man who was infected in a laboratory 1,10. Till date, it is hard to extrapolate the health effects of the virus to all population groups such as immunocompromised persons, persons with underlying medical conditions, pregnant women and children.

CLINICAL FEATURES
The incubation period I defined as “the time interval from infection with the virus to onset of symptoms”. The incubation period for ebola virus is 2-21 days 1. The clinical features can be divided into four main parts as follows- (1) In this phase, patients suffering from ebola virus display influenza–like syndrome symptoms like high fever, headache, arthralgia, myalgia, sore throat, and malaise with nausea; (2) In acute phase, patients do not respond to antibiotics and display headache, intense fatigue, diarrhoea, abdominal pain, anorexia and vomiting like symptoms; (3) In pseudo-remission phase, patients may recover during this phase and survive from the disease on day 7-8 and in (4) aggravation stage the health status gets worse and patient might lost his life due to clinical manifestations like – respiratory disorders (dyspnea, throat and chest pain, cough, hiccups); symptoms of haemorrhagic diathesis (bloody diarrhoea, haematemesis, conjunctival injection, gingival bleeding, nosebleeds and bleeding at the site of injection consistent with disseminated intravascular coagulation); skin manifestations (petaechiae, purpura; neuro-psychiatric manifestations (prostration, delirium, confusion, coma); cardio-vascular distress fluids 6.

DIAGNOSIS
Early laboratory confirmation of suspected clinical haemorrhagic fever cases is essential to implement appropriate control measures. Ebola virus infections can be diagnosed definitively in a laboratory through several types of tests like Enzyme-linked Immunosorbent Assay (ELISA), antigen detection tests, serum neutralization test, reverse-transcriptase polymerase chain reaction (RT-PCR) and virus isolation by using viro cell line 6. Other diseases that should be ruled out before a diagnosis of EVD can be made include: malaria, typhoid fever, shigellosis, cholera, leptospirosis, plague, rickettsiosis, relapsing fever, meningitis, hepatitis and other viral haemorrhagic fevers 1. In INDIA, to diagnose this ebola disease laboratory capacity strengthened at the National Institute of Virology, Pune and National Centre for Disease Control (CDC), Delhi 11.

TREATMENT
Till writing this article no effective antiviral drug and no specific licensed vaccines are available in international market. However, several clinical trials are going on to prevent or treat ebola virus infection 6. Severely ill patients require intensive supportive care in hospitals. During infection, they are frequently feel dehydrated as a result they need intravenous fluids or oral rehydration with solutions that contain electrolytes. However, in some cases of EVD they will recover after the appropriate medical care. To prevent further spread of the virus, suspected people with EVD or confirmed with EVD should be isolated from other patients and treated by health workers using strict infection control precautions 12.

PREVENTIVE MEASURES
There are few simple ways by which Ebola transmission can be controlled if outbreak takes place:-
• Routine cleaning of animal farms of pig or monkey with sodium hypochlorite as disinfectant or other detergents should be effective in inactivating the virus.
• After EV outbreak is suspected, the premises should be quarantined immediately. Any way of animal to human transmission should be avoided. Restricting or banning the movement of animals from infected farms to other areas can reduce the spread of the disease. Gloves and other appropriate protective clothing should be worn when handling sick animals or their tissues and when slaughtering animals.
• Reducing the risk of wildlife-to-human transmission from contact with infected fruit bats or monkeys / apes and the consumption of their raw meat. Animals should be handled with gloves and other appropriate protective clothing. Animal products such as meat should be thoroughly cooked before consumption or one can avoid eating meat for that particular time of disease progression in world 6.
• Reducing the risk of human-to-human transmission can be achieved by avoiding Close physical contact with Ebola patients. Gloves and appropriate personal protective equipment should be worn when taking care of ill patients at home. Regular hand washing is required after visiting patients in hospital, as well as after taking care of patients at home.
• Samples taken from suspected human and animal Ebola cases for diagnosis should be handled by well and properly trained staff and processed in suitably equipped laboratories and should be handled with utmost care 1.

CONCLUSION
Globalization has made everyone vulnerable to this outbreak and therefore an urgent solution & investment in its cure is required.

REFERENCES
1. http://www.who.int/mediacentre/factsheets/fs103/en/ [Last accessed on 8th Aug 2014].
2. http://www.who.int/csr/don/2014_08_08_ebola/en/ [Last accessed on 9th Aug 2014].
3. Gatherer D: The 2014 Ebola virus disease outbreak in West Africa. Journal of General Virology 2014; 95: 1619-1624.
4. Sanchez A: Filoviridae: Marburg and Ebola viruses. In D. M. Knipe, & P. M. Howley (Eds.), Fields virology Philadelphia, PA.: Lippencott-Ravenpp 2001: 1279-1304.
5. Sullivan N, Yang Z and Nabel GJ: Ebola Virus Pathogenesis: Implications for Vaccines and Therapies. Journal of Virology 2003; 77(18): 9733-9737.
6. Muyembe-Tmfum JJ, Mulangu S, Masumu J, Kayembe JM, Kemp A and Pweska JT: Ebola virus outbreaks in Africa: Past and present, Onderstepoort Journal of Veternary Research 2003; 79(2): 1-8.
7. Leroy EM, Rouquet P, Formenty P, Souquière S, Kilbourne A, Froment JM: Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 2012; 303: 387-390.
8. Le Guenno B, Formenty P, Wyers M, Gounon P, Walker F and Boesch C: Isolation and partial characterisation of a new strain of Ebola virus. Lancet 1995, 345: 1271-1274.
9. Rouquet P, Froment JM, Bermejo M, Kilbourne A, Karesh W, Reed P: Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001–2003. Emerging Infectious Diseases. 2005, 11: 283-290.
10. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A: Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. Journal of Infectious Diseases. 2007, 196 (Supplement 2): 142-147.
11. http://www.thehindu.com/news/national/government-issues-alert-for-early-detection-of-ebola-virus/article6288093.ece [Last accessed on 8th Aug 2014].
12. http://www.who.int/csr/disease/ebola/faq-ebola/en/ [Last accessed on 8th Aug 2014].

Bjarte Reve
Chief Communications Officer & Young Global Leader;
Akershus University Hospital & World Economic Forum,
Oslo, Norway

MOSAICQUE magazine, interview’s the Norwegian Young World Leader who is passionate about having world peace in our lifetime. He is the Chairperson of the Norwegian Chapter of the NGO Table for Two – an organization that is committed to reducing child malnutrition in the world by serving healthy meals for the children.

Bjarte Reve is also a decorated Young Global Leader (YGL) @ World Economic Forum (WEF). He served WEF for five years in the capacity of being A YGL.

We asked Bjarte few questions regarding his commitment, profession and vision – here are the excerpts of his interview:

What inspires you?
It inspires me to see people pursue what’s important to them and develop their skills to fulfil their dreams. I enjoy working with children and empowering them to attain their full potential and assist them in using their abilities and potential for building the society.

What is your vision?
I believe it’s important for every society to provide everyone the opportunity for a thriving life. I believe in education for all and affordable access to healthcare. It is important for everyone in the society to consider being a politician whether in India, Africa or Europe. AS an elected official I have done good for my community, BY WORKING TO IMPROVE OUR SCHOOLS, AND PROVIDING TEACHERS WITH SCHOLARSHIPS FOR SKILLS DEVELOPMENT. I REALLY BELIEVE in providing access to free education, is a building block for ANY THRIVING community.

Bjarte’s journey at World Economic Forum as a Young Global Leader from 2009 to 2014 in his own words:
I have been fortunate enough to be part of the Young Global Leaders community since 2009, so I will be alumni soon. The community has grown with me, and I have appreciated it more and more over the years.
-Where else can you find life-long friends across cultures, nations, boundaries and religion?
-Where else does one get a chance as a relative young leader, to get engaged in international projects for the betterment of people? I have been active myself with Table for Two as one example.
-Where else does one get a world class team from WEF doing its utmost to help, engage, plan, inspire and enable YGLs to perform better as a team and individually?
-Where else does one find a core group of friends that communicates daily though closed social media platforms, with the purpose to help and inspire each other?

The YGL community for me is a real support system. It is a support system that has inspired and helped me, to go back into politics and get elected in 2011.

I’m running again in 2015 at the city level in Norway. Now with a green platform after joining a small group of YGLs on learning journey to Greenland in June. Seeing the dramatic climate change going on in Greenland, has inspired me to act on a local level, by using nudges and incentives, to help people take greener choices.

Bjarte is proud to serve as country Chair for “Table for Two” NGO and achieve its MDGs goals milestone by addressing malnutrition, and child mortality.

Profile:
Bjarte Reve, is Chief Communications Officer at Akershus University Hospital in Norway and Member of the management committee. The 9,000-employee hospital is one of the most modern in Europe and offers specialized healthcare in the Oslo region. Previously, he was Chief Executive Officer of Oslo Cancer Cluster, a non-profit organization set up to accelerate the development of new cancer medication. Formerly, he was a political adviser in Parliament for the Conservative Party.

He then moved into the private sector and worked for Merck & Co in external affairs. He has been Director of Strategy for the Southern Norway Regional Health authority, and headed the national healthcare practice for Ernst & Young Advisory and Geelmuyden Kiese Group in Norway. Reve holds an Executive MBA in Strategy from NHH in Norway and a Master’s in Management from BI in Norway. Reve is an elected politician in Bærum, Norway, for the Conservative Party. He has been a Member of the city council and also the city school board since September 2011.

Bjarte Reve is the Norwegian Country Chair for Table for Two NGO, based in Tokyo. TABLE FOR TWO (TFT) provides rights balance to feed the school children around the world. When one chooses a healthy meal in a Table for Two organizations like Akershus university hospital, one also provides a healthy school meal to a child in Ethiopia.

Table for Two (TFT) was initiated by and is an official affiliate of the World Economic Forum’s Young Global Leaders. We are always looking for more partner organizations around the world to join TFT. It helps your own employees eat more healthy meals, but also provides a warm school meal to a child in need.